Dr. Reddy’s Laboratories launches Sodium Nitroprusside Injection

30 Dec 2019 Evaluate

Dr. Reddy's Laboratories has launched Sodium Nitroprusside Injection, 50 mg/2 ml (25 mg/ml) Single-dose Vial, the therapeutic generic equivalent of Nitropress (sodium nitroprusside) Injection, 50 mg/2ml vial, approved by the U.S. Food and Drug Administration (USFDA).

The Nitropress brand and generics had U.S. sales of approximately $8 million MAT for the most recent twelve months ending in October 2019 according to IQVIA Health. The company’s Sodium Nitroprusside Injection is available in single-dose 50 mg/2 ml (25 mg/ml) vials.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharm aceuticals in India and overseas.

Dr. Reddys Lab Share Price

5922.45 43.40 (0.74%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.